ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 323

Immunoprecipitation and Advanced Proteomics for the Discovery of Novel Antigenic Targets in Juvenile Idiopathic Arthritis

Ginger L. Janow1, Cristina Clement2, Norman T. Ilowite3, Laura Santambrogio2 and Steven A. Porcelli4, 1Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, 2Pathology Department, Albert Einstein College of Medicine, Bronx, NY, 3Pediatrics, The Children's Hospital at Montefiore, Bronx, NY, 4Microbiology& Immunology, Albert Eistein College of Medicine, Bronx, NY

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile idiopathic arthritis (JIA) and proteomics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic condition seen by pediatric rheumatologists.  The pathogenesis of disease is poorly understood, but is believed to be mediated by an adaptive immune response involving auto-reactive B-cells and T-cells.  There are high concentrations of immune complexes in the joint but specificities of these immune complexes are unknown.  We hypothesize that joint destruction is partly the result of an adaptive immune response mediated by antibodies, and that examination of peptides and proteins in the synovial fluid (SF) of children with JIA combined with the identification of antigens targeted by antibodies found in arthritic SF will help clarify the pathogenesis of JIA.

Methods: Subjects with JIA with active arthritis of the knee requiring intra-articular corticosteroid injection were recruited from our pediatric rheumatology clinic.  Subjects seen by pediatric orthopedics requiring arthroscopic knee surgery for traumatic injuries were recruited as controls.  SF was collected from the knee of 4 children with JIA and 2 orthopedic controls.  Specimens were diluted, centrifuged, and filtered.  Peptidome and proteome were separated  with ultrafiltration spin columns and advanced MS/MS was carried out. Protein A&G was used to isolate IgG inclusive immune-complexes. Antigens were eluted with glycine and analyzed using  trypsin restriction with MS/MS.  Ingenuity pathway analysis was used to analyze the proteome. 

Results: High concentrations of immune complexes were found in the joints of JIA patients, nearing 50% of the total sample.  Pathway analysis of the proteomes revealed statistically significant overlap with 5 relevant canonical pathways in all patients: acute phase response signaling, complement activation, coagulation system, intrinsic prothrombin activation, and extrinsic prothrombin activation.  Peptidome analysis revealed the breakdown products of structural components including multiple collagen subtypes.  Antibody-targeted antigens present in three out of the 4 patients but absent in controls were alpha-1-antitrypsin precursor, hyaluronan binding protein, haptoglobin, and protein S100-A9. 

Conclusion: Proteome analysis confirmed the validity of our methods, revealing significant overlap with 5 pathways already known to be important in the pathogenesis of JIA.  Given the role of short peptides as antigenic targets of T cell responses, the composition of the peptidome in the synovial tissues and fluids of JIA patients is likely to contribute to disease associated adaptive immune responses.  The preliminary finding of the breakdown products of structural components suggests a mechanism for amplification of the autoimmune process during inflammation.  While the role of the identified antibody-targeted antigens in pathogenesis remains unclear, it is of interest that some of these proteins, including alpha-1-antitrypsin and protein S100-A9 have been implicated as biological markers in both adult RA and JIA.  Future research will validate the presence of these antibodies in a larger sample.  These antibodies could have potential roles as biomarkers for disease and as targets for treatment.


Disclosure:

G. L. Janow,
None;

C. Clement,
None;

N. T. Ilowite,
None;

L. Santambrogio,
None;

S. A. Porcelli,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immunoprecipitation-and-advanced-proteomics-for-the-discovery-of-novel-antigenic-targets-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology